PRS has become a ‘tie-breaker’ for clinical decision-making in patients with uncertain risk profiles, giving us confidence we need to make the most effective treatment decisions.
PRS testing helps guide decisions in uncertain cases, brings clarity to patients with unexplained events, and facilitates more personalized, thoughtful discussions about risk.
This document outlines an approach for using a Polygenic Risk Score (PRS) in a Coronary Artery Disease (CAD) clinical pathway.